|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 36:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gilmore TD and Wolenski FS: NF-κB: Where
did it come from and why? Immunol Rev. 246:14–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayden MS and Ghosh S: NF-κB in
immunobiology. Cell Res. 21:223–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayden MS and Ghosh S: Regulation of NF-κB
by TNF family cytokines. Semin Immunol. 26:253–266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maeda S and Omata M: Inflammation and
cancer: Role of nuclear factor-kappaB activation. Cancer Sci.
99:836–842. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Greten FR, Eckmann L, Greten TF, Park JM,
Li ZW, Egan LJ, Kagnoff MF and Karin M: IKKbeta links inflammation
and tumorigenesis in a mouse model of colitis-associated cancer.
Cell. 118:285–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakshatri H, Bhat-Nakshatri P, Martin DA,
Goulet RJ Jr and Sledge GW Jr: Constitutive activation of NF-kappaB
during progression of breast cancer to hormone-independent growth.
Mol Cell Biol. 17:3629–3639. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lindholm PF, Bub J, Kaul S, Shidham VB and
Kajdacsy-Balla A: The role of constitutive NF-kappaB activity in
PC-3 human prostate cancer cell invasive behavior. Clin Exp
Metastasis. 18:471–479. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang W, Abbruzzese JL, Evans DB, Larry L,
Cleary KR and Chiao PJ: The nuclear factor-kappa B RelA
transcription factor is constitutively activated in human
pancreatic adenocarcinoma cells. Clin Cancer Res. 5:119–127.
1999.PubMed/NCBI
|
|
13
|
Sakamoto K, Maeda S, Hikiba Y, Nakagawa H,
Hayakawa Y, Shibata W, Yanai A, Ogura K and Omata M: Constitutive
NF-kappaB activation in colorectal carcinoma plays a key role in
angiogenesis, promoting tumor growth. Clin Cancer Res.
15:2248–2258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hagemann T, Wilson J, Kulbe H, Li NF,
Leinster DA, Charles K, Klemm F, Pukrop T, Binder C and Balkwill
FR: Macrophages induce invasiveness of epithelial cancer cells via
NF-kappa B and JNK. J Immunol. 175:1197–1205. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stathopoulos GT, Sherrill TP, Han W,
Sadikot RT, Yull FE, Blackwell TS and Fingleton B: Host nuclear
factor-kappaB activation potentiates lung cancer metastasis. Mol
Cancer Res. 6:364–371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo JL, Maeda S, Hsu LC, Yagita H and
Karin M: Inhibition of NF-kappaB in cancer cells converts
inflammation-induced tumor growth mediated by TNFalpha to
TRAIL-mediated tumor regression. Cancer Cell. 6:297–305. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Pan WH, Clawson GA and Richmond A:
Systemic targeting inhibitor of kappaB kinase inhibits melanoma
tumor growth. Cancer Res. 67:3127–3134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh AP, Buscaglia CA, Wang Q, Levay A,
Nussenzweig DR, Walker JR, Winzeler EA, Fujii H, Fontoura BM and
Nussenzweig V: Plasmodium circumsporozoite protein promotes the
development of the liver stages of the parasite. Cell. 131:492–504.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kappe SH, Buscaglia CA and Nussenzweig V:
Plasmodium sporozoite molecular cell biology. Annu Rev Cell Dev
Biol. 20:29–59. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalderon D, Roberts BL, Richardson WD and
Smith AE: A short amino acid sequence able to specify nuclear
location. Cell. 39:499–509. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar KA, Sano G, Boscardin S, Nussenzweig
RS, Nussenzweig MC, Zavala F and Nussenzweig V: The
circumsporozoite protein is an immunodominant protective antigen in
irradiated sporozoites. Nature. 444:937–940. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frevert U, Galinski MR, Hügel FU, Allon N,
Schreier H, Smulevitch S, Shakibaei M and Clavijo P: Malaria
circumsporozoite protein inhibits protein synthesis in mammalian
cells. EMBO J. 17:3816–3826. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baud V and Karin M: Is NF-kappaB a good
target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov.
8:33–40. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bharti AC, Donato N, Singh S and Aggarwal
BB: Curcumin (diferuloylmethane) down-regulates the constitutive
activation of nuclear factor-kappa B and IkappaBalpha kinase in
human multiple myeloma cells, leading to suppression of
proliferation and induction of apoptosis. Blood. 101:1053–1062.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
LoTempio MM, Veena MS, Steele HL,
Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES
and Wang MB: Curcumin suppresses growth of head and neck squamous
cell carcinoma. Clin Cancer Res. 11:6994–7002. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kunnumakkara AB, Guha S, Krishnan S,
Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates
antitumor activity of gemcitabine in an orthotopic model of
pancreatic cancer through suppression of proliferation,
angiogenesis, and inhibition of nuclear factor-kappaB-regulated
gene products. Cancer Res. 67:3853–3861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sandur SK, Deorukhkar A, Pandey MK, Pabón
AM, Shentu S, Guha S, Aggarwal BB and Krishnan S: Curcumin
modulates the radiosensitivity of colorectal cancer cells by
suppressing constitutive and inducible NF-kappaB activity. Int J
Radiat Oncol Biol Phys. 75:534–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kunnumakkara AB, Diagaradjane P, Guha S,
Deorukhkar A, Shentu S, Aggarwal BB and Krishnan S: Curcumin
sensitizes human colorectal cancer xenografts in nude mice to
gamma-radiation by targeting nuclear factor-kappaB-regulated gene
products. Clin Cancer Res. 14:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aggarwal BB, Shishodia S, Takada Y,
Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin
suppresses the paclitaxel-induced nuclear factor-kappaB pathway in
breast cancer cells and inhibits lung metastasis of human breast
cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schön M, Wienrich BG, Kneitz S,
Sennefelder H, Amschler K, Vöhringer V, Weber O, Stiewe T,
Ziegelbauer K and Schön MP: KINK-1, a novel small-molecule
inhibitor of IKKbeta, and the susceptibility of melanoma cells to
antitumoral treatment. J Natl Cancer Inst. 100:862–875. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moschos SJ, Chaudhary PM and Kirkwood JM:
Resolving ‘kinks’ of chemotherapy in melanoma. J Natl Cancer Inst.
100:833–835. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bilsland AE, Anderson CJ,
Fletcher-Monaghan AJ, McGregor F, Evans TR, Ganly I, Knox RJ, Plumb
JA and Keith WN: Selective ablation of human cancer cells by
telomerase-specific adenoviral suicide gene therapy vectors
expressing bacterial nitroreductase. Oncogene. 22:370–380. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wirth T, Zender L, Schulte B, Mundt B,
Plentz R, Rudolph KL, Manns M, Kubicka S and Kühnel F: A
telomerase-dependent conditionally replicating adenovirus for
selective treatment of cancer. Cancer Res. 63:3181–3188.
2003.PubMed/NCBI
|
